Armistice Capital »

Jasper Therapeuritc shares owned by Armistice Capital

Quarter-by-quarter ownership of Jasper Therapeuritc (JSPR) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Jasper Therapeuritc

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeuritc held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeuritc by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $828k 348k 2.38

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Jasper Therapeuritc

Velan Capital Investment Management
Soleus Capital Management
Acorn Capital Advisors
Kingdon Capital Management
Rock Springs Capital Management
Carlyle
Woodline Partners
Vanguard Group
T. Rowe Price Investment Management
Propel Bio Management
Qiming U.S. Ventures Management
Morgan Stanley
Citadel Advisors
Sphera Funds Management
Simplify Asset Management

View all funds holding Jasper Therapeuritc